Review

Published on 28 Nov 2014

Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity

in Neuropharmacology

Georgina L. Thompson
Meritxell Canals
Daniel P. Poole

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00262

5,751 views
27 citations

Original Research

Published on 27 Nov 2014

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe

in Experimental Pharmacology and Drug Discovery

Omar Patiño-Rodríguez
Irma Torres-Roque
Maricela Martínez-Delgado
Abraham Escobedo-Moratilla
José Pérez-Urizar

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00261

8,614 views
10 citations

Review

Published on 27 Nov 2014

Improving the safety of cell therapy products by suicide gene transfer

in Experimental Pharmacology and Drug Discovery

Benjamin S. Jones
Lawrence S. Lamb
Frederick Goldman
Antonio Di Stasi

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00254

23,357 views
159 citations

Original Research

Published on 27 Nov 2014

Glutathione revisited: a better scavenger than previously thought

in Experimental Pharmacology and Drug Discovery

Guido R. M. M. Haenen
Aalt Bast

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00260

6,528 views
32 citations

Original Research

Published on 26 Nov 2014

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

in Experimental Pharmacology and Drug Discovery

Manoranjenni Chetty
Rachel H. Rose
Khaled Abduljalil
Nikunjkumar Patel
Gaohua Lu
Theresa Cain
Masoud Jamei
Amin Rostami-Hodjegan

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00258

10,719 views
47 citations

Mini Review

Published on 25 Nov 2014

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine

in Neuropharmacology

Ginetta Collo
Laura Cavalleri
PierFranco Spano

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00259

11,510 views
50 citations

Hypothesis and Theory

Published on 25 Nov 2014

GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area

in Neuropharmacology

Elena Vashchinkina
Anne Panhelainen
Teemu Aitta-aho
Esa R. Korpi

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00256

30,040 views
23 citations

Original Research

Published on 21 Nov 2014

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging

in Experimental Pharmacology and Drug Discovery

Israa Qawasmi
Miriam Shmuel
Sara Eyal

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00257

3,946 views
3 citations

Original Research

Published on 18 Nov 2014

Analysis of biomarker utility using a PBPK/PD model for carbaryl

in Predictive Toxicology

Martin B. Phillips
Miyoung Yoon
Bruce Young
Yu-Mei Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00246

5,039 views
8 citations

Review

Published on 17 Nov 2014

Does the kappa opioid receptor system contribute to pain aversion?

in Neuropharmacology

Catherine M. Cahill
Anna M. W. Taylor
Christopher Cook
Edmund Ong
Jose A. Morón
Christopher J. Evans

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00253

18,244 views
79 citations

Mini Review

Published on 12 Nov 2014

In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants

in Integrative and Regenerative Pharmacology

William H. Peranteau

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00251

4,559 views
10 citations

Book Review

Published on 12 Nov 2014

Should I have this on my bookshelf? A review of Cardiac Drugs in Pregnancy

in Obstetric and Pediatric Pharmacology

Michael J. Rieder

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00249

3,245 views

General Commentary

Published on 12 Nov 2014

Gene expression and highly diluted molecules

in Ethnopharmacology

Marta Marzotto
Debora Olioso
Paolo Bellavite

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00237

9,153 views
8 citations

Original Research

Published on 11 Nov 2014

PPARγ SIGNALING IS REQUIRED FOR MEDIATING EETS PROTECTIVE EFFECTS IN NEONATAL CARDIOMYOCYTES EXPOSED TO LPS

in Experimental Pharmacology and Drug Discovery

Victor Samokhvalov
Jelle Vriend
Kristi L Jamieson
Maria Akhnokh
Rajkumar Manne
John R Falck
John M. Seubert

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00242

5,562 views
27 citations

Review

Published on 11 Nov 2014

The role of drug transporters in the kidney: lessons from tenofovir

in Experimental Pharmacology and Drug Discovery

Darren M. Moss
Megan Neary
Andrew Owen

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00248

15,967 views
61 citations

Mini Review

Published on 10 Nov 2014

Inside epoxyeicosatrienoic acids and cardiovascular disease

in Experimental Pharmacology and Drug Discovery

Stefania Tacconelli
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00239

7,326 views
40 citations

Navigation group

Articles

Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity

Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe

Improving the safety of cell therapy products by suicide gene transfer

Glutathione revisited: a better scavenger than previously thought

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine

GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging

Analysis of biomarker utility using a PBPK/PD model for carbaryl

Does the kappa opioid receptor system contribute to pain aversion?

In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants

Should I have this on my bookshelf? A review of Cardiac Drugs in Pregnancy

Gene expression and highly diluted molecules

PPARγ SIGNALING IS REQUIRED FOR MEDIATING EETS PROTECTIVE EFFECTS IN NEONATAL CARDIOMYOCYTES EXPOSED TO LPS

The role of drug transporters in the kidney: lessons from tenofovir

Inside epoxyeicosatrienoic acids and cardiovascular disease